vs
Side-by-side financial comparison of Dayforce (DAY) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
Dayforce is the larger business by last-quarter revenue ($481.6M vs $270.8M, roughly 1.8× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -40.9%, a 41.6% gap on every dollar of revenue. On growth, Dayforce posted the faster year-over-year revenue change (9.5% vs -16.5%).
Dayforce, Inc., formerly Ceridian, is an American human resources software and services company.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
DAY vs HCM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $481.6M | $270.8M |
| Net Profit | $-196.8M | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | 6.3% | -13.2% |
| Net Margin | -40.9% | 0.7% |
| Revenue YoY | 9.5% | -16.5% |
| Net Profit YoY | -9940.0% | -83.6% |
| EPS (diluted) | $-1.23 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $270.8M | ||
| Q3 25 | $481.6M | — | ||
| Q2 25 | $464.7M | $277.7M | ||
| Q1 25 | $481.8M | $324.5M | ||
| Q4 24 | $465.2M | — | ||
| Q3 24 | $440.0M | — | ||
| Q2 24 | $423.3M | $305.7M | ||
| Q1 24 | $431.5M | — |
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-196.8M | — | ||
| Q2 25 | $21.3M | $455.0M | ||
| Q1 25 | $14.9M | $11.9M | ||
| Q4 24 | $10.8M | — | ||
| Q3 24 | $2.0M | — | ||
| Q2 24 | $-1.8M | $25.8M | ||
| Q1 24 | $7.1M | — |
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q4 24 | 47.0% | — | ||
| Q3 24 | 45.8% | — | ||
| Q2 24 | 44.1% | 41.1% | ||
| Q1 24 | 47.6% | — |
| Q4 25 | — | -13.2% | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 9.1% | -1.3% | ||
| Q1 25 | 6.4% | -5.0% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 3.3% | -9.0% | ||
| Q1 24 | 9.4% | — |
| Q4 25 | — | 0.7% | ||
| Q3 25 | -40.9% | — | ||
| Q2 25 | 4.6% | 163.8% | ||
| Q1 25 | 3.1% | 3.7% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | -0.4% | 8.4% | ||
| Q1 24 | 1.6% | — |
| Q4 25 | — | $0.00 | ||
| Q3 25 | $-1.23 | — | ||
| Q2 25 | $0.13 | $0.52 | ||
| Q1 25 | $0.09 | $0.01 | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $0.01 | — | ||
| Q2 24 | $-0.01 | $0.03 | ||
| Q1 24 | $0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $627.6M | $1.4B |
| Total DebtLower is stronger | $631.1M | $93.2M |
| Stockholders' EquityBook value | $2.7B | $1.2B |
| Total Assets | $8.7B | $1.8B |
| Debt / EquityLower = less leverage | 0.23× | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.4B | ||
| Q3 25 | $627.6M | — | ||
| Q2 25 | $625.2M | $1.4B | ||
| Q1 25 | $557.3M | $836.1M | ||
| Q4 24 | $579.7M | — | ||
| Q3 24 | $494.1M | — | ||
| Q2 24 | $465.4M | $802.5M | ||
| Q1 24 | $392.5M | — |
| Q4 25 | — | $93.2M | ||
| Q3 25 | $631.1M | — | ||
| Q2 25 | $631.8M | $93.4M | ||
| Q1 25 | $632.4M | $82.8M | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | $82.1M | ||
| Q1 24 | $1.2B | — |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $2.7B | — | ||
| Q2 25 | $2.7B | $1.2B | ||
| Q1 25 | $2.6B | $759.9M | ||
| Q4 24 | $2.5B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.5B | $740.1M | ||
| Q1 24 | $2.4B | — |
| Q4 25 | — | $1.8B | ||
| Q3 25 | $8.7B | — | ||
| Q2 25 | $8.5B | $1.8B | ||
| Q1 25 | $9.5B | $1.3B | ||
| Q4 24 | $9.1B | — | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $9.0B | $1.3B | ||
| Q1 24 | $10.8B | — |
| Q4 25 | — | 0.08× | ||
| Q3 25 | 0.23× | — | ||
| Q2 25 | 0.23× | 0.08× | ||
| Q1 25 | 0.24× | 0.11× | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.49× | 0.11× | ||
| Q1 24 | 0.50× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $31.2M | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.2M | ||
| Q3 25 | $31.2M | — | ||
| Q2 25 | $112.7M | $-72.9M | ||
| Q1 25 | $49.6M | $40.3M | ||
| Q4 24 | $81.0M | — | ||
| Q3 24 | $91.8M | — | ||
| Q2 24 | $99.2M | $-39.8M | ||
| Q1 24 | $9.1M | — |
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.29× | -0.16× | ||
| Q1 25 | 3.33× | 3.38× | ||
| Q4 24 | 7.50× | — | ||
| Q3 24 | 45.90× | — | ||
| Q2 24 | — | -1.54× | ||
| Q1 24 | 1.28× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DAY
| Dayforce Recurring | $333.0M | 69% |
| Cloud And Bureau Professional Services And Other | $78.5M | 16% |
| Float | $42.2M | 9% |
| Powerpay Recurring | $19.7M | 4% |
| Other Recurring | $8.2M | 2% |
HCM
Segment breakdown not available.
